Literature DB >> 3392040

Purification of a factor required for transcription of vaccinia virus early genes.

S S Broyles1, L Yuen, S Shuman, B Moss.   

Abstract

Partially purified DNA-dependent RNA polymerase from infectious vaccinia virus particles exhibits the following two activities: 1) specific transcription of double-stranded DNA templates containing vaccinia early promoters and 2) nonspecific transcription of single-stranded DNA templates. After further purification of the RNA polymerase, specific transcriptase activity was selectively diminished suggesting the loss of a transcription factor. In agreement with the latter hypothesis, transcriptase activity could be reconstituted by mixing the purified RNA polymerase with certain column fractions. A quantitative complementation assay was developed and used to locate the transcription factor during successive column chromatography steps. The factor eluted as a single peak of activity from single strand DNA-cellulose and phosphocellulose columns. An observation that the transcription factor binds specifically to vaccinia early promoter sequences was exploited in the final affinity chromatography steps. The purified factor was separated from all previously identified vaccinia enzymes and contained two polypeptides of Mr 77,000 and 82,000. A DNA-dependent ATPase activity also copurified with the transcription factor. Although a single template was used for assays during isolation, the purified factor stimulated transcription of three other early genes by 20-30-fold suggesting that it has a general role in conferring promoter specificity for initiation of early transcription.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3392040

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  64 in total

1.  Ternary complex formation by vaccinia virus RNA polymerase at an early viral promoter: analysis by native gel electrophoresis.

Authors:  J Hagler; S Shuman
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

2.  In vitro recognition of an orf virus early promoter in a vaccinia virus extract.

Authors:  J C Vos; A A Mercer; S B Fleming; A J Robinson
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

3.  Reverse genetics analysis of poxvirus intermediate transcription factors.

Authors:  Robin D Warren; Catherine A Cotter; Bernard Moss
Journal:  J Virol       Date:  2012-06-27       Impact factor: 5.103

4.  Vaccinia virion protein VP8, the 25 kDa product of the L4R gene, binds single-stranded DNA and RNA with similar affinity.

Authors:  C D Bayliss; G L Smith
Journal:  Nucleic Acids Res       Date:  1997-10-15       Impact factor: 16.971

5.  Characterization of a 7-kilodalton subunit of vaccinia virus DNA-dependent RNA polymerase with structural similarities to the smallest subunit of eukaryotic RNA polymerase II.

Authors:  B Y Amegadzie; B Y Ahn; B Moss
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

6.  The vaccinia virus B1R gene product is a serine/threonine protein kinase.

Authors:  S Lin; W Chen; S S Broyles
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

7.  The conserved poxvirus L3 virion protein is required for transcription of vaccinia virus early genes.

Authors:  Wolfgang Resch; Bernard Moss
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

8.  Genome-wide analysis of the 5' and 3' ends of vaccinia virus early mRNAs delineates regulatory sequences of annotated and anomalous transcripts.

Authors:  Zhilong Yang; Daniel P Bruno; Craig A Martens; Stephen F Porcella; Bernard Moss
Journal:  J Virol       Date:  2011-04-13       Impact factor: 5.103

9.  Cascade regulation of vaccinia virus gene expression is modulated by multistage promoters.

Authors:  Zhilong Yang; Liliana Maruri-Avidal; Jerry Sisler; Carey A Stuart; Bernard Moss
Journal:  Virology       Date:  2013-10-03       Impact factor: 3.616

10.  Purification of a yeast TATA box-binding protein that exhibits human transcription factor IID activity.

Authors:  M Horikoshi; C K Wang; H Fujii; J A Cromlish; P A Weil; R G Roeder
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.